Evaluation of the Risk Mitigation Guidance in British Columbia: Interim Findings

Injectable Opioid Assisted Treatment (iOAT) cost effectiveness and evidence review by the Canadian Agency for Drugs and Technology in Health (CADTH)

Reducing harm through the development of good preparation practices for the injection of slow release morphine sulphate



Be the first to comment

Please check your e-mail for a link to activate your account.